Research code: 23053
Ethics code: 23053
Zahra Kateb 
, Alireza Gandomi-Mohammadabadi , Mahdi Yadollahzadeh , Mohammad Amin Abbasi * , Shahin Keshtkar Rajabi
, Alireza Gandomi-Mohammadabadi , Mahdi Yadollahzadeh , Mohammad Amin Abbasi * , Shahin Keshtkar Rajabi
, amin.abbasi1314@gmail.com
Abstract: (124 Views)
Abstract:
Introduction and purpose: The 2019 coronavirus disease (COVID-19) was first identified in China in December 2019 and was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. It has changed the acute management for many patients, including patients with pulmonary arterial hypertension. Patients with pulmonary arterial hypertension (PAH) usually have better outcomes when they are admitted to the hospital compared to other pathologies. Therefore, the current covid-19 epidemic has created a special challenge for these patients. In this study, by examining patients hospitalized due to covid-19 in the first 6 months of 1400 in Firouzabadi Hospital, the relationship between pulmonary hypertension and severity and We investigated the consequences of the covid disease, in order to reduce the mortality rate of patients with pulmonary hypertension by providing them with the necessary measures and reducing the severity of pulmonary hypertension.
method: This retrospective cross-sectional study was conducted on pulmonary hypertension patients admitted to the covid department of Firouzabadi Hospital. The required information of the patients, such as age, sex, and other background diseases, were extracted from their files and recorded in the predetermined checklists. After completing the checklist and equalizing all the influencing factors, the obtained data were analyzed using SPSS v.22 statistical software, and the effect of pulmonary hypertension and other variables on the mortality of patients was investigated.
Findings: In the current study, the prevalence of PH was 14% (29 people), with a minimum age of 26, a maximum age of 88 and a mean age of 51.1. The second group without phtn included 171 patients with a minimum age of 2 and a maximum age of 91 and an average age of 47.8. In normal pap patients: 46.2% were women and 53.8% were men. In abnormal pap patients: 72.4% were women and 27.6% were men. A significant relationship was observed between gender and pap of patients. In the present study, out of 29 patients with abnormal pap, 5 had underlying diseases. Out of 29 patients with abnormal pap, 15 patients were transferred to ICU (55.1%). There was a significant relationship between age and hospitalization in ICU in both groups of patients. Out of 29 patients with abnormal pap, 8 patients died (27.5%). A significant relationship was seen between mortality and age in abnormal pap patients and mortality and age in normal pap patients. In this study. In our study, the initial EF of the patients had no effect on the mortality of the patients. Among the patients, 59 patients (29.5%) were admitted to ICU and 53 patients (26.5%) died. In patients with pulmonary hypertension, 15 patients (41.75%) were admitted to ICU and 10 patients (27.8%) died, and in patients with normal pulmonary blood pressure, 44 patients (26.8%) were admitted to ICU and 43 patients (26.2%) died, and no significant statistical difference was observed (P<0.05).
Conclusion: The prevalence of PH was 14% (29 people). Out of a total of 29 patients, 16 (55.1%) were transferred to intensive care, 8 of the 29 admitted patients (27.5%) eventually died. The risk of death in patients with covid and PAP is not higher than the risk of death in patients with covid alone, and both need supportive treatment measures.
Introduction and purpose: The 2019 coronavirus disease (COVID-19) was first identified in China in December 2019 and was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. It has changed the acute management for many patients, including patients with pulmonary arterial hypertension. Patients with pulmonary arterial hypertension (PAH) usually have better outcomes when they are admitted to the hospital compared to other pathologies. Therefore, the current covid-19 epidemic has created a special challenge for these patients. In this study, by examining patients hospitalized due to covid-19 in the first 6 months of 1400 in Firouzabadi Hospital, the relationship between pulmonary hypertension and severity and We investigated the consequences of the covid disease, in order to reduce the mortality rate of patients with pulmonary hypertension by providing them with the necessary measures and reducing the severity of pulmonary hypertension.
method: This retrospective cross-sectional study was conducted on pulmonary hypertension patients admitted to the covid department of Firouzabadi Hospital. The required information of the patients, such as age, sex, and other background diseases, were extracted from their files and recorded in the predetermined checklists. After completing the checklist and equalizing all the influencing factors, the obtained data were analyzed using SPSS v.22 statistical software, and the effect of pulmonary hypertension and other variables on the mortality of patients was investigated.
Findings: In the current study, the prevalence of PH was 14% (29 people), with a minimum age of 26, a maximum age of 88 and a mean age of 51.1. The second group without phtn included 171 patients with a minimum age of 2 and a maximum age of 91 and an average age of 47.8. In normal pap patients: 46.2% were women and 53.8% were men. In abnormal pap patients: 72.4% were women and 27.6% were men. A significant relationship was observed between gender and pap of patients. In the present study, out of 29 patients with abnormal pap, 5 had underlying diseases. Out of 29 patients with abnormal pap, 15 patients were transferred to ICU (55.1%). There was a significant relationship between age and hospitalization in ICU in both groups of patients. Out of 29 patients with abnormal pap, 8 patients died (27.5%). A significant relationship was seen between mortality and age in abnormal pap patients and mortality and age in normal pap patients. In this study. In our study, the initial EF of the patients had no effect on the mortality of the patients. Among the patients, 59 patients (29.5%) were admitted to ICU and 53 patients (26.5%) died. In patients with pulmonary hypertension, 15 patients (41.75%) were admitted to ICU and 10 patients (27.8%) died, and in patients with normal pulmonary blood pressure, 44 patients (26.8%) were admitted to ICU and 43 patients (26.2%) died, and no significant statistical difference was observed (P<0.05).
Conclusion: The prevalence of PH was 14% (29 people). Out of a total of 29 patients, 16 (55.1%) were transferred to intensive care, 8 of the 29 admitted patients (27.5%) eventually died. The risk of death in patients with covid and PAP is not higher than the risk of death in patients with covid alone, and both need supportive treatment measures.
Send email to the article author
